Convey Holding Parent Inc (NY:CNVY)

N/A UNCHANGED

Last Price Updated: 7:00 PM EDT, Oct 6, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Convey Holding Parent Inc

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Convey Health Solutions Holdings, Inc.’s Directors for Breach of Fiduciary Duties – CNVY

August 15, 2022

From Scott+Scott Attorneys at Law LLP

Via Business Wire

NYSE:CNVY Investor Alert: Investigation over Potential Wrongdoing at Convey Health Solutions Holdings, Inc. ↗

August 12, 2022

San Diego, CA -- (SBWIRE) -- 08/12/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Convey Health Solutions Holdings, Inc.

Via SBWire

Monster Moves Among Russell 3,000 Stocks ↗

August 08, 2022

Even though equities have hit the pause button on the rally off of the late spring lows over the past few days, there have been some monster moves across a number of Russell 3,000 stocks.

Via Talk Markets

INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Convey Health Solutions Holdings, Inc. with Losses of $100,000 to Contact the Firm

July 05, 2022

From The Schall Law Firm

Via Business Wire

TPG Capital Takes Healthcare Technology Convey Health Private In $1B Deal ↗

June 21, 2022

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Convey Health Solutions Holdings, Inc. with Losses of $100,000 to Contact the Firm

July 02, 2022

From The Schall Law Firm

Via Business Wire

Convey Health Solutions Holdings, Inc. (NYSE:CNVY) Shareholder Notice: Investigation of Takeover ↗

June 28, 2022

San Diego, CA -- (SBWIRE) -- 06/28/2022 -- An investigation was announced for investors, who currently hold shares of Convey Health Solutions Holdings, Inc. (NYSE:CNVY), concerning whether the takeover...

Via SBWire

Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2022 ↗

June 22, 2022

Upgrades

Via Benzinga

67 Biggest Movers From Yesterday ↗

June 22, 2022

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.

Via Benzinga

SHAREHOLDER ALERT: Labaton Sucharow Researching Possible Wrongdoing – Convey Health Solutions Holdings, Inc.

June 21, 2022

From Labaton Sucharow LLP

Via Business Wire

Nasdaq Rises 2.5%; ACADIA Pharmaceuticals Shares Plummet ↗

June 21, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 2.5% on Tuesday.

Via Benzinga

Dow Up Over 550 Points as Markets Attempt Rebound ↗

June 21, 2022

With no specific driver pushing stocks higher, many on Wall Street expect today's bounce to fall flat.

Via Talk Markets

Dow Jumps 550 Points; Convey Health Solutions Shares Spike Higher ↗

June 21, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 550 points on Tuesday.

Via Benzinga

45 Stocks Moving In Tuesday's Mid-Day Session ↗

June 21, 2022

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.

Via Benzinga

Why Convey Health Solutions Shares Are Skyrocketing Today ↗

June 21, 2022

Convey Health Solutions Holdings Inc (NYSE: CNVY) shares are trading higher by 138.45% to $10.30 after the company announced it will be taken private by TPG.

Via Benzinga

U.S. Markets Open Higher; Lennar Earnings Top Views ↗

June 21, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 500 points on Tuesday.

Via Benzinga

Convey Holding Parent's Return on Invested Capital Overview ↗

June 14, 2022

Benzinga Pro data, Convey Holding Parent (NYSE:CNVY) reported Q1 sales of $96.71 million. Earnings fell to a loss of $1.15 million, resulting in a 379.42% decrease from last quarter.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 13, 2021

Gainers Biolase (NASDAQ:BIOL) stock increased by 38.01% to $0.87 during Friday's regular session. Trading volume for this security as of 12:35 EST is 80.8 million,...

Via Benzinga

IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings ↗

June 14, 2021

This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going...

Via Benzinga

Topics Initial Public Offering

Earnings Scheduled For March 23, 2022 ↗

March 23, 2022

Companies Reporting Before The Bell • AYRO (NASDAQ:AYRO) is expected to report earnings for its fourth quarter. • First Trust NASDAQ Clean Edge Smart Grid...

Via Benzinga

78 Biggest Movers From Friday ↗

August 16, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering. Flora Growth...

Via Benzinga

53 Stocks Moving In Friday's Mid-Day Session ↗

August 13, 2021

Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The company said it continues to experience demand...

Via Benzinga

61 Biggest Movers From Yesterday ↗

July 23, 2021

Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company announced new results from its TATX-03 PolyTope Therapy...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

July 20, 2021

Before 10 a.m. ET Tuesday, 64 stocks made new 52-week lows. Key Facts: TotalEnergies (NYSE:TTE) was the largest, in terms of market cap, to set a new 52-week low....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2021 ↗

July 12, 2021

Upgrades According to Macquarie, the prior rating for 2U Inc (NASDAQ:

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.